SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-180042
Filing Date
2022-06-23
Accepted
2022-06-23 16:02:57
Documents
13
Period of Report
2022-06-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d730888d8k.htm   iXBRL 8-K 43616
2 EX-3.1 d730888dex31.htm EX-3.1 179538
  Complete submission text file 0001193125-22-180042.txt   379867

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA teva-20220623.xsd EX-101.SCH 2864
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20220623_lab.xml EX-101.LAB 17914
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20220623_pre.xml EX-101.PRE 11240
7 EXTRACTED XBRL INSTANCE DOCUMENT d730888d8k_htm.xml XML 3622
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 221035427
SIC: 2834 Pharmaceutical Preparations